Thermo Fisher Scientific (TMO) Revenue (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Revenue for 18 consecutive years, with $11.0 billion the latest figure, recorded in Q1 2026.

• Revenue for Q1 2026 came in at $11.0 billion, up 6.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.2 billion (up 5.36% YoY), and the FY2025 annual result was $44.6 billion, up 3.91% from the prior year.
• Revenue was $11.0 billion for Q1 2026 at Thermo Fisher Scientific, down from $12.2 billion in the prior quarter.
• Over five years, Revenue peaked at $12.2 billion in Q4 2025 and troughed at $10.3 billion in Q1 2024.
• Average Revenue over 5 years is $11.0 billion, with a median of $10.9 billion recorded in 2025.
• Year-over-year, Revenue gained 19.3% in 2022 and decreased 9.38% in 2023.
• Over 5 years, Revenue stood at $11.5 billion in 2022, then declined by 4.93% to $10.9 billion in 2023, then rose by 4.68% to $11.4 billion in 2024, then advanced by 7.2% to $12.2 billion in 2025, then dropped by 9.91% to $11.0 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $11.0 billion in Q1 2026, $12.2 billion in Q4 2025, and $11.1 billion in Q3 2025.